WASHINGTON (AP) — The Supreme Court will decide this summer whether to allow generic drug makers to be sued for not trying to get federal regulators to add warnings about potentially dangerous side effects to their drug labels.
The high court on Wednesday heard arguments from PLIVA Inc., which is trying to stop lawsuits against it.
Gladys Mensing says taking a generic drug caused her neurological disorder, but none of the manufacturers included any label warnings.
Recommended For You
Generic drug makers say government regulations require them to have the same label as the brand-name equivalent. The drug did not have a warning about the neurological disorder mentioned in the lawsuit
Justices seemed fairly split on the issue.
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
